Terms: = Leukemia AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
17 results:
1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia.
Zheng Y; Pan L; Li J; Feng X; Li C; Zheng M; Mai H; Yang L; He Y; He X; Xu H; Wen H; Le S
BMC Cancer; 2024 Jan; 24(1):46. PubMed ID: 38195455
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of neurotrophin receptor-interacting melanoma-associated antigen homolog inhibits acute myeloid leukemia cell growth via the ERK pathway.
Zhang H; Wu G; Chen B
Chin J Physiol; 2023; 66(4):276-283. PubMed ID: 37635487
[TBL] [Abstract] [Full Text] [Related]
4. Expression of telomerase reverse transcriptase in peripheral T-cell lymphoma.
Arakawa F; Miyoshi H; Yoshida N; Nakashima K; Watatani Y; Furuta T; Yamada K; Moritsubo M; Takeuchi M; Yanagida E; Shimasaki Y; Kohno K; Kataoka K; Ohshima K
Cancer Med; 2021 Oct; 10(19):6786-6794. PubMed ID: 34477310
[TBL] [Abstract] [Full Text] [Related]
5. Mechanism of Human Telomerase Reverse Transcriptase (
Yik MY; Azlan A; Rajasegaran Y; Rosli A; Yusoff NM; Moses EJ
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440361
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of BAMBI and SMAD7 impacts prognosis of acute myeloid leukemia patients: A potential tert non-canonical role.
Shehata MM; Sallam AM; Naguib MG; El-Mesallamy HO
Cancer Biomark; 2021; 31(1):47-58. PubMed ID: 33780363
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds].
Wei T; Chen XJ; Zhang LY; Zhang AL; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1279-1285. PubMed ID: 33327998
[TBL] [Abstract] [Full Text] [Related]
8. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H
Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children.
Wang M; Wen J; Guo Y; Shen Y; An X; Hu Y; Xiao J
PLoS One; 2019; 14(12):e0224652. PubMed ID: 31830053
[TBL] [Abstract] [Full Text] [Related]
10. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A
Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599
[TBL] [Abstract] [Full Text] [Related]
11. Epigenetic landscape of the tert promoter: a potential biomarker for high risk AML/MDS.
Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
[TBL] [Abstract] [Full Text] [Related]
12. Acquired tert promoter mutations stimulate tert transcription in mantle cell lymphoma.
Panero J; Alves-Paiva RM; Roisman A; Santana-Lemos BA; Falcão RP; Oliveira G; Martins D; Stanganelli C; Slavutsky I; Calado RT
Am J Hematol; 2016 May; 91(5):481-5. PubMed ID: 26852175
[TBL] [Abstract] [Full Text] [Related]
13. Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.
Salaverria I; Martín-Garcia D; López C; Clot G; García-Aragonés M; Navarro A; Delgado J; Baumann T; Pinyol M; Martin-Guerrero I; Carrió A; Costa D; Queirós AC; Jayne S; Aymerich M; Villamor N; Colomer D; González M; López-Guillermo A; Campo E; Dyer MJ; Siebert R; Armengol L; Beà S
Genes Chromosomes Cancer; 2015 Nov; 54(11):668-80. PubMed ID: 26305789
[TBL] [Abstract] [Full Text] [Related]
14. Association between tert promoter polymorphisms and acute myeloid leukemia risk and prognosis.
Mosrati MA; Willander K; Falk IJ; Hermanson M; Höglund M; Stockelberg D; Wei Y; Lotfi K; Söderkvist P
Oncotarget; 2015 Sep; 6(28):25109-20. PubMed ID: 26298771
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
[TBL] [Abstract] [Full Text] [Related]
16. Telomerase gene mutation screening and telomere overhang detection in Chinese patients with acute myeloid leukemia.
Yan S; Han B; Wu Y; Zhou D; Zhao Y
Leuk Lymphoma; 2013 Jul; 54(7):1437-41. PubMed ID: 23157242
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of a human telomerase reverse transcriptase sequence containing two antigenic epitopes with high affinity for human leucocyte antigen.
Wang J; Yu L; Li J; Deng R; Wang X
Biotechnol Appl Biochem; 2007 Oct; 48(Pt 2):93-9. PubMed ID: 17868023
[TBL] [Abstract] [Full Text] [Related]
